ArticleiScience2026

Immunotherapy Efficacy in SMARC-Altered Cancers: A pan-cancer analysis of clinical outcomes in response to immune checkpoint inhibition.

Gregory P Botta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.